P&G Studios and Harder Than You Think Foster Game Changing Conversations in New Podcast Series “Equal Too: Achieving Disability Equality”
26.8.2021 20:15:00 EEST | Business Wire | Press release
Today, P&G Studios and the team at Harder Than You Think launch a new podcast series, “Equal Too: Achieving Disability Equality,” to shine a light on the biggest challenges faced by the disabled community and start a conversation about what is needed to drive equality. The podcast, hosted by UK television presenter and disability advocate Sophie Morgan, will focus on challenging perceptions, celebrating successes, and exploring how to transform the world for those who do and do not have a disability. Sophie will speak with some of the most informed and most famous professionals, influencers, and activists about key themes of disability and inclusion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210826005660/en/
P&G Studios and the team at Harder Than You Think launch a new podcast series, “Equal Too: Achieving Disability Equality,” to shine a light on the biggest challenges faced by the disabled community and start a conversation about what is needed to drive equality. (Graphic: Business Wire)
“Equal Too” is a special six-part series featured on the podcast Seneca’s Conversations on Power and Purpose and is brought to you by the Seneca Women Podcast Network and iHeart Radio. The series will run through August and September and will explore thought-provoking topics, like:
- The legacy of the Paralympic Movement and the lasting impact hosting the Paralympic Games has had on host cities and beyond
- How legislation for disabled people is changing and what more needs to be done
- The path of employment for disabled people 70 years after Sir Ludwig Guttmann began using sport to create space for disabled people in society
For “Equal Too,” the talented team behind the award-winning Netflix documentary Rising Phoenix have brought together an abundance of voices who are policymakers, activists, athletes, and allies from across the globe, including:
- Jameela Jamil, actor and host recognized as an advocate for disability rights, LGBTQ+ rights, body neutrality, and her work as founder of the I Weigh Community
- RJ Mitte, an American actor, advocate, and philanthropist who has been a global champion in speaking of his experiences with Cerebral Palsy in hopes of removing the stigma associated with disabilities
- Tatyana McFadden, a Russian-American athlete who holds 17 Paralympic medals, whose efforts to advocate for disability equality led to the passage of several pieces of legislation to ensure students with disabilities have equal access to compete in athletics
- Andrew Parsons, a Brazilian sports administrator, and the president of the International Paralympic Committee (IPC). The IPC and the International Disability Alliance recently spearheaded the launch of the #WeThe15 campaign, a global movement to represent the 1.2 billion people with disabilities in the world
“With ‘Equal Too’ bringing together so many powerful and influential voices, it will help us to work out where the Rising Phoenix story needs to go next,” said Greg Nugent, co-founder of Harder Than You Think and creator of Rising Phoenix. “The threads to the conversation are extraordinary and important and the need for the story to be told is more vital than ever.”
As the world turns its focus to the incredible athletes competing in the Paralympic Games and inspired by the recent launch of the IPC’s #WeThe15 initiative, the biggest disability equality movement of its kind, P&G is committing a $100,000 donation to the Agitos Foundation. This will help fuel the work of the IPC to change how young people perceive those with a disability.
“We believe that greater visibility is a critical step to changing perceptions on the journey to disability equality,” said Phil Duncan, P&G’s Chief Design Officer and Olympic Games Executive. “We all have more to learn, which is why it’s important for us to spotlight the hugely important conversations in ‘Equal Too.’ We are also proud to make a monetary donation to the Agitos Foundation, which is doing incredibly impactful work in raising long lasting awareness for the next generation.”
As meaningful conversations about inclusivity can only be made possible when equal voices are represented, “Equal Too” is made possible by a team – from producers to guests and contributors – comprised of more than 60% of people who identify as disabled. At the helm of the project are two influential women: host and executive producer Sophie Morgan and executive producer and story consultant Sinéad Burke. Sophie, who was paralyzed in a car crash when she was 18, is an award-winning broadcaster who has presented for Channel 4 at every Paralympic Games since the Paralympic Games London 2012 and is one of the first and only female, disabled television hosts in the world. Sinéad, the founder of accessibility consultancy, Tilting the Lens, is a little person who campaigns to raise the baseline standards of accessibility to build a world that is designed with disabled people, for the inclusion of all.
All episodes of the podcast will be released with downloadable transcripts available shortly thereafter. Additionally, they will be accompanied with captioned videos featuring a deaf British Sign Language signer, Rinkoo Barpaga. You can download and listen to “Equal Too,” part of Seneca's Conversations, on the iHeartradio App, Apple Podcasts, or whichever podcast player you use.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at www.pg.com/news.
About P&G Studios
P&G Studios develops and produces stories to help create positive change in society, often shining the light on under-represented voices and acts of good. Like-minded, mission-based creative innovators and innovative NGO organizations partner with P&G Studios to meet the growing demand for authentic stories that uplift and inspire. Recent programs include The Queen Collective and 8:46 films, the National Geographic ACTIVATE Series, The Tent Mender documentary series, TIME 100 Most Influential People of the Year and TIME Person of the Year one-hour specials, Coded short documentary, and the launch of the Seneca Women’s Podcast Network.
About Harder Than You Think
Harder Than You Think is an independent production company whose purpose is to help change the way we think using the power of the story. Harder Than You Think was created and co-founded by Greg Nugent and Godric Smith, formerly Directors of the London 2012 Olympics and Paralympics. Greg and Godric’s work includes the creation of the Heads Together Campaign for Their Royal Highnesses using film, which went on to transform the views of the nation on mental health, and the creation of The Earthshot Prize, which has become the most important award on the plant for action on the environment.
Rising Phoenix is a ten-year mission by Harder Than You Think that aims to change the way the world thinks about human potential. The project was born out of the success of Harder Than You Think's debut film ‘Rising Phoenix,’ a landmark and double Emmy winning feature documentary about the history of the Paralympic Movement released in 2020 on Netflix, and via further films and audio projects in development to tell the story of the next decade.
About Seneca Women
Co-founded by Ambassador Melanne Verveer, the first U.S. Ambassador for Global Women’s Issues, and Kim Azzarelli, a corporate, philanthropic and legal advisor, who together co-authored the best-selling book Fast Forward: How Women Can Achieve Power and Purpose, and joined by Sharon Bowen, former Commissioner of the U.S. Commodity Futures Trading Commission, Seneca Women has sought to accelerate women’s progress through signature thought leadership events at Davos, the Metropolitan Museum of Art and the New York Stock Exchange, as well as through the Seneca Women app, a weekly newsletter, and significant partnerships with the public and private sectors. The Seneca Women Podcast Network provides a platform for the voices of women as well as inspiring, purpose-driven and inclusive content.
About iHeartMedia
iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month – and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The company’s leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210826005660/en/
Contact information
Samantha Policano, MMK+
(202) 835-9495
samantha.policano@ketchum.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 13:38:00 EEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 12:48:00 EEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
